T Iu Obergan Selected Research

prolyl-glycyl-prolyl-leucine

1/2013	[Cholesterol-lowering effect of the regulatory peptide Pro-Gly-Pro-Leu].
5/2010	[Fibrinolytic and hypoglycemic effects of the Pro-Gly-Pro-Leu peptide during development of insulin-dependent diabetes in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Iu Obergan Research Topics

Disease

2	Hyperglycemia 05/2013 - 01/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2010 - 11/2009
2	Diabetes Mellitus 11/2009 - 05/2006
1	Body Weight (Weight, Body) 01/2013
1	Hypercholesterolemia 01/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Experimental Diabetes Mellitus 09/2004

Drug/Important Bio-Agent (IBA)

5	Peptides (Polypeptides)IBA 05/2013 - 11/2009
3	AlloxanIBA 05/2010 - 05/2006
2	prolyl-glycyl-prolyl-leucineIBA 01/2013 - 05/2010
2	AnticoagulantsIBA 01/2013 - 09/2004
1	leucylprolineIBA 05/2013
1	glycylproline (Gly-Pro)IBA 05/2013
1	CholesterolIBA 01/2013
1	FatsIBA 01/2013
1	SugarsIBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	LipidsIBA 01/2013
1	MargarineIBA 01/2013
1	Arg-Pro-Gly-ProIBA 01/2012
1	Heparin (Liquaemin)FDA LinkGeneric 01/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2009
1	prolyl-glycyl-prolineIBA 11/2009
1	prolylglycineIBA 11/2009
1	Hemostatics (Antihemorrhagics)IBA 09/2004
1	CoagulantsIBA 09/2004

Therapy/Procedure

2	Intranasal Administration 05/2013 - 01/2012